Networks
Clinical Studies (1)
- PanoramicNOR : Study aims to assess whether a 5-day course of nirmatrelvir/ritonavir treatment for patients with acute COVID-19 can reduce the prevalence of persistent symptoms at 3 months compared to placebo
External Links
Other information
If you would like to contact the site, please email: ccb@ateneo.univr.it
The data is updated up to